Oncology 2020: a drug development and approval paradigm

被引：21
作者：
Dhingra, K. [1 ]
机构：
[1] KAPital Consulting LLC, Sparta, NJ 07871 USA
来源：
ANNALS OF ONCOLOGY | 2015年 / 26卷 / 11期
关键词：
D O I：
10.1093/annonc/mdv353
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2347 / 2350
页数：4
相关论文
共 50 条
  • [41] A New Paradigm in Drug Development
    Bouille, Pascale
    BIOPHARM INTERNATIONAL, 2018, 31 (08) : 26 - +
  • [42] A new paradigm for drug development
    Burki, Talha
    LANCET DIGITAL HEALTH, 2020, 2 (05): : E226 - E227
  • [43] Tracking the FDA precision oncology drug approval landscape in OncoKB.
    Suehnholz, Sarah Phillips
    Kundra, Ritika
    Zhang, Hongxin
    Nissan, Moriah H.
    Lu, Calvin
    Dhaneshwar, Amanda
    Fernandez, Nicole
    Nandakumar, Subhiksha
    Arcila, Maria E.
    Ladanyi, Marc
    Berger, Michael F.
    Syed, Aijazuddin
    Brannon, Angela Rose
    Levine, Ross L.
    Dogan, Ahmet
    Drilon, Alexander E.
    Solit, David B.
    Schultz, Nikolaus
    Chakravarty, Debyani
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [44] Paving the path towards tissue-agnostic drug approval in oncology
    Le Tourneau, C.
    Bieche, I.
    Kamal, M.
    ANNALS OF ONCOLOGY, 2024, 35 (11) : 930 - 932
  • [45] Efforts to accelerate the process of drug development and approval
    不详
    CANCER BIOLOGY & THERAPY, 2006, 5 (06) : 566 - 567
  • [46] Innovation in Oncology Drug Development
    Huber, Matthew
    Huber, Brian
    JOURNAL OF ONCOLOGY, 2019, 2019
  • [47] MR in oncology drug development
    Galbraith, Susan M.
    NMR IN BIOMEDICINE, 2006, 19 (06) : 681 - 689
  • [48] Modifying the drug discovery drug development paradigm
    Lloyd, A
    DRUG DISCOVERY TODAY, 1997, 2 (10) : 397 - 398
  • [49] Drug development in paediatric oncology
    Benninger-Doering, G.
    Boos, J.
    KLINISCHE PADIATRIE, 2006, 218 (03): : 152 - 156
  • [50] The role of the pharmaceutical industry in drug development and approval
    Beleau, MH
    VETERINARY AND HUMAN TOXICOLOGY, 1998, 40 : 17 - 19
12345